News

Company News

Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round

Cambridge, MA, March 24, 2017 – Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round.  The company is developing novel small molecule drugs that limit neuronal damage in patients that have suffered a stroke, traumatic brain injury (TBI) or concussion. The seed financing round […]

0 comments

Former Army TBI Research Leader Col. Dallas Hack Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

Cambridge, MA, December 19, 2016 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company’s Scientific Advisory Board. Astrocyte Pharmaceuticals is developing novel small molecule therapeutics for acute administration to patients who have suffered a stroke, traumatic brain injury (TBI) or concussion. […]

0 comments

Leading Emergency Clinician David W. Wright Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

Cambridge, MA, October 19, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that David W. Wright, M.D., has joined the company’s Scientific Advisory Board. Astrocyte Pharmaceuticals is developing breakthrough small molecule therapeutics for acute administration to patients who have suffered a traumatic brain injury (TBI), concussion or stroke. “Dr. Wright is […]

0 comments

In the Media

Astrocyte mentioned in StatNews article “A Pill for Concussions Remains a Brain-Busting Challenge” by Cassandra Willyard.

“To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells” article in Xconomy by David Holley.

Company Profile published by Nature Biopharma Dealmakers in the September 2015 issue dedicated to Neuroscience companies and their research.

Pursuing Concussion’s Cure” article in the Mission magazine by Will Samsom

Article by San Antonio Business Journal previewing presentation at The Health Cell’s State of the Industry event

Coverage by International Innovation in the May 20th 2014 issue (Issue 142), “A Brainy Bunch (free registration required)

Coverage by CBS Dallas reporter Brian New

Developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders